Angiotensin II for the Treatment of COVID-19-Related Vasodilatory Shock.

Chow, Jonathan H; Mazzeffi, Michael A; McCurdy, Michael T

Chow, Jonathan H; Mazzeffi, Michael A; McCurdy, Michael T.

Chow JH; From the Departments of Anesthesiology.
Mazzeffi MA; From the Departments of Anesthesiology.
McCurdy MT; Medicine and Emergency Medicine, University of Maryland School of Medicine, Baltimore, Maryland.

Anesth Analg ; 131(1): 102-105, 2020 07.

Article in English | MEDLINE | ID: covidwho-599940

Subject(s)

Angiotensin II/therapeutic use; Coronavirus Infections/complications; Pneumonia, Viral/complications; Shock/etiology; Shock/therapy; Vasoconstrictor Agents/therapeutic use; COVID-19; Coronavirus Infections/physiopathology; Coronavirus Infections/therapy; Humans; Pandemics; Pneumonia, Viral/physiopathology; Pneumonia, Viral/therapy; Shock/physiopathology

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Shock / Vasoconstrictor Agents / Angiotensin II / Coronavirus Infections Topics: Long Covid Limits: Humans Language: English Journal: Anesth Analg Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google